Perbedaan Harga & Kinerja Ashmore Asset Management Indonesia Tbk (AMOR) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga
Pergerakan harga dalam 24 jam terakhir
Statistik utama
Statistik utama
Perbedaan Ashmore Asset Management Indonesia Tbk dan Tempo Scan Pacific Tbk.: Ashmore Asset Management Indonesia Tbk diperdagangkan di Rp322 (kapitalisasi pasar 715,56 M, volume 24 jam 25,9 rb), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.470 (kapitalisasi pasar 11,23 T, volume 24 jam 699,1 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 15,7× kapitalisasi pasar Ashmore Asset Management Indonesia Tbk, dan Tempo Scan Pacific Tbk. lebih aktif diperdagangkan (699,1 rb vs 25,9 rb). Mana yang lebih baik tergantung tujuan investasimu.
| AMOR | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 715,56 M | 11,23 T |
Volume | 25,9 rb | 699,1 rb |
Lot | 259 | 6,99 rb |
Perputaran | 8,31 jt | 1,75 M |
Harga Rata-rata | 320,73 | 2.496,22 |
Nilai Transaksi | 8,31 jt | 1,75 M |
Harga Ekuilibrium Indikatif | 322 | 2.470 |
Volume Ekuilibrium Indikatif | 1 | 90 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Ashmore Asset Management Indonesia Tbk
PT Ashmore Asset Management Indonesia Tbk (the Company) initially established under the name of PT Buana Megah Abadi, is an Indonesian domiciled Company. The Company was established based on notary deed No. 250 dated 29 January 2010 of Doctor Irawan Soerodjo, SH.MSi.
Selengkapnya di halaman AMOR →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
